Greater Occipital Nerve and Cervical Region Injection in Patients With Trigeminal Neuralgia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 29
- 试验地点
- 1
- 主要终点
- Efficacy on pain severity
研究概览
简要总结
The aim of this study is to investigate the efficacy of greater occipital nerve block and cervical injections with lidocaine
详细描述
After being informed about the study and potantiel risks, all patients giving informed consent will undergo randomization in 1:1 ratio to 1% lidocaine or 0.9% saline groups
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Classical Trigeminal Neuralgia
排除标准
- •Secondary Trigeminal Neuralgia
研究组 & 干预措施
Active
%1 lidocaine injections to greater occipital nerve and cervical region once a week for 4 weeks
干预措施: Lidocaine 1% Injectable Solution (Drug)
结局指标
主要结局
Efficacy on pain severity
时间窗: 3 months
Efficacy on pain scores. Visual Analogue Scale (VAS). VAS is a ten-point scale where zero refers to no pain and ten refers to maximal pain
Efficacy on pain frequency
时间窗: 3 months
Pain frequency per day
次要结局
未报告次要终点
研究者
Cem Bölük
Principal Investigator
Dr. Lutfi Kirdar Kartal Training and Research Hospital